Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype

G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs

(2021) Germana Bancone et al.   Frontiers in Pharmacology

Incorporating G6PD genotyping to identify patients with G6PD deficiency

(2021) Sarah A. Morris et al.   Pharmacogenetics and Genomics

Glucose-6-Phosphate Dehydrogenase Deficiency

(2020) Lucio Luzzatto et al.   BLOOD

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria

(2019) Marcus V.G. Lacerda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of essential medicines lists in 137 countries

(2019) Nav Persaud et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Favism and Glucose-6-Phosphate Dehydrogenase Deficiency

(2018) Lucio Luzzatto et al.   NEW ENGLAND JOURNAL OF MEDICINE

Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies

(2018) Katherine M. Robinson et al.   PHARMACOGENOMICS JOURNAL

What G6PD-deficient individuals should really avoid

(2016) Shaun Wen Huey Lee et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Mortality Following Rasburicase-Induced Methemoglobinemia

(2014) Mason H. Bucklin et al.   ANNALS OF PHARMACOTHERAPY

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype

(2014) M V Relling et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone

(2012) A. Pamba et al.   BLOOD

Glucose-6-phosphate dehydrogenase (G6PD) mutations database: Review of the “old” and update of the new mutations

(2012) Angelo Minucci et al.   BLOOD CELLS MOLECULES AND DISEASES

Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network

(2012) Stephanie M. Fullerton et al.   GENETICS IN MEDICINE

Glucose-6-Phosphate Dehydrogenase Deficiency and Borderline Deficiency: Association with Neonatal Hyperbilirubinemia

(2012) Arieh Riskin et al.   JOURNAL OF PEDIATRICS

Intermediate values of glucose-6-phosphate dehydrogenase

(2012) Michael Kaplan et al.   JOURNAL OF PEDIATRICS

Quantitative Neonatal Glucose-6-Phosphate Dehydrogenase Screening: Distribution, Reference Values, and Classification by Phenotype

(2012) Nurit Algur et al.   JOURNAL OF PEDIATRICS

Lethal Effect of a Single Dose of Rasburicase in a Preterm Newborn Infant

(2012) P. Zaramella et al.   PEDIATRICS

Risk Assessment for Adverse Outcome in Term and Late Preterm Neonates with Bilirubin Values of 20 mg/dL or More

(2011) Yi-Hao Weng et al.   AMERICAN JOURNAL OF PERINATOLOGY

Medications and Glucose-6-Phosphate Dehydrogenase Deficiency

(2010) Ilan Youngster et al.   DRUG SAFETY

The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis

(2009) Ella T. Nkhoma et al.   BLOOD CELLS MOLECULES AND DISEASES

Unexpected glucose-6-phosphate dehydrogenase deficiency

(2008) Wing-Yan Au et al.   BRITISH JOURNAL OF HAEMATOLOGY

Glucose-6-phosphate dehydrogenase deficiency

(2008) MD Cappellini et al.   LANCET